E34.09
Other carcinoid syndrome
Billable FY2026 2025-10-01 → 2026-09-30
FY2025–2027 only
Exclusions 4 never code together
Instructional notes 7
E34.0code
E34.09code
Inclusion terms
- Carcinoid disease NEC
- Carcinoid syndrome NEC
- Other carcinoid disease
E00-E89chapter
Notes
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8E07.0E16-E31E34.-
Index entries leading here 9
- Syndrome — see also Disease
- Argentaffinoma — see also Neoplasm, uncertain behavior, by site
- syndrome E34.09
- Björck (-Thorson) syndrome (malignant carcinoid) E34.09
- Secretion
- hormone
- by
- carcinoid tumor E34.09
- by
- hormone
- Disease, diseased — see also Syndrome
- Cassidy (-Scholte) syndrome (malignant carcinoid) E34.09
- Flush syndrome E34.09
- Scholte's syndrome (malignant carcinoid) E34.09
- Thorson-Björck syndrome E34.09
Alongside this code 2 same parent — E34.0
Medications 1
MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.
Additional references
AHA Coding Clinic® Licence required
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.